Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
EyePoint Pharmaceuticals, Inc. | Director | Restricted Stock Units | 10K | $204K | $20.40 | Jan 5, 2024 | Direct |
EyePoint Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 25K | Jan 5, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
EYPT | EyePoint Pharmaceuticals, Inc. | Jan 5, 2024 | 3 | $0 | 4 | Jan 9, 2024 | Director |
EYPT | EyePoint Pharmaceuticals, Inc. | Jun 20, 2023 | 2 | $0 | 4 | Jun 22, 2023 | Director |
EYPT | EyePoint Pharmaceuticals, Inc. | Feb 9, 2023 | 2 | $0 | 4 | Feb 13, 2023 | Director |
EYPT | EyePoint Pharmaceuticals, Inc. | Feb 9, 2022 | 4 | $0 | 4 | Feb 11, 2022 | Director |
EYPT | EyePoint Pharmaceuticals, Inc. | Jun 22, 2021 | 2 | $0 | 4 | Jun 23, 2021 | Director |